Search
for
Sort by
Research 151–180 of 1000+
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- The Risk of Benign Prostatic Hyperplasia and Prostate Cancer With Long-Term, Low Dose Finasteride Use in Adult Men with Nonscarring Alopecia: A Propensity-Matched Observational Study
- Population-level risk of erectile dysfunction after finasteride use for androgenetic alopecia: a national cohort analysis
- Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study
- Comparison of Linear Regression, Decision Tree Regression, and Random Forest Regression Algorithms in Predicting Baldness Risk
- Depression risk of 5-alpha reductase inhibitors: A systematic review and meta-analysis with a focus on comparator groups
- Increased risk of telogen effluvium with tirzepatide compared to other weight-loss medications: a retrospective cohort TriNetX database study
- Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss
- Similar Risk of Sexual Dysfunction in Androgenetic Alopecia Patients Treated With Dutasteride vs. Finasteride: A Retrospective Cohort Database Study
- Lifestyle Risk Factors in Male Androgenetic Alopecia: A Cross-sectional Study
- Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
- Evaluation of the Environmental Risk Factors and Comorbidities in Patients with Lichen Planopilaris: A Case-Control Study
- The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia and androgenetic alopecia: A population‐based case–control study
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- OR20-01 Machine Learning-based Steroid Metabolome Analysis In Women With Polycystic Ovary Syndrome Reveals Three Distinct Androgen Excess Subtypes With Different Metabolic Risk Profiles.
- An Expert System for Clinical Risk Assessment of Polycystic Ovary Syndrome under Uncertainty
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Perceived predation risk predicts glucocorticoid hormones, but not reproductive success in a colonial rodent
- Cardiovascular risk in patients with selected cutaneous diseases
- High-risk male teenager with concurrent gonorrhea and syphilis infection: An alarming call
- Cross-Sectional Study Of The Association Between Skin Tags And Vascular Risk Factors In A Bariatric Clinic-Based Cohort Of Irish Adults With Morbid Obesity
- 578 Addressing the missing components for appropriate surveillance of Merkel cell carcinoma patients: Detailed recurrence data and an integrated risk analysis approach
- Alopecia areata susceptibility variant identified by MHC risk haplotype sequencing reproduces symptomatic patched hair loss in mice
- Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele
- 1726: Risk Decrease of Intra-Operative Bleeding During TURP with the Uptake of Finasteride: Evaluation of VEGF and CD34
- A Study on Association between Androgenetic Alopecia and Cardiovascular Risk Factors in Males with History of Hair Fall